Castleark Management LLC Vericel Corp Transaction History

Castleark Management LLC

  • $2.41 Billion
  • Q3 2024

A detailed history of Castleark Management LLC transactions in Vericel Corp stock. As of the latest transaction made, Castleark Management LLC holds 78,020 shares of VCEL stock, worth $4.61 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
78,020
Previous 142,060 45.08%
Holding current value
$4.61 Million
Previous $6.52 Million 49.42%
% of portfolio
0.14%
Previous 0.27%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$42.25 - $53.56 $2.71 Million - $3.43 Million
-64,040 Reduced 45.08%
78,020 $3.3 Million
Q2 2024

Aug 13, 2024
BUY
$41.71 - $52.9 $492,595 - $624,749
11,810 Added 9.07%
142,060 $6.52 Million
Q1 2024

May 15, 2024
SELL
$32.52 - $52.33 $577,880 - $929,904
-17,770 Reduced 12.01%
130,250 $6.78 Million
Q4 2023

Feb 14, 2024
SELL
$30.85 - $37.09 $4,319 - $5,192
-140 Reduced 0.09%
148,020 $5.27 Million
Q3 2023

Nov 15, 2023
BUY
$31.69 - $39.25 $578,976 - $717,097
18,270 Added 14.07%
148,160 $4.97 Million
Q2 2023

Aug 15, 2023
BUY
$29.0 - $38.37 $3.77 Million - $4.98 Million
129,890 New
129,890 $4.88 Million
Q2 2022

Aug 16, 2022
SELL
$22.88 - $39.45 $3.34 Million - $5.75 Million
-145,770 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$31.69 - $43.29 $4.62 Million - $6.31 Million
145,770 New
145,770 $5.57 Million
Q4 2021

Feb 16, 2022
SELL
$35.2 - $52.6 $5.39 Million - $8.06 Million
-153,160 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$46.35 - $59.75 $2.07 Million - $2.67 Million
-44,630 Reduced 22.56%
153,160 $7.47 Million
Q2 2021

Aug 17, 2021
BUY
$47.2 - $67.81 $9.34 Million - $13.4 Million
197,790 New
197,790 $10.4 Million
Q3 2020

Nov 16, 2020
SELL
$14.68 - $19.12 $4.06 Million - $5.29 Million
-276,760 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$8.5 - $15.82 $347,097 - $646,009
40,835 Added 17.31%
276,760 $3.83 Million
Q1 2020

May 13, 2020
BUY
$7.25 - $19.22 $296,017 - $784,752
40,830 Added 20.93%
235,925 $2.16 Million
Q4 2019

Feb 14, 2020
BUY
$13.77 - $19.2 $2.69 Million - $3.75 Million
195,095 New
195,095 $3.4 Million
Q2 2019

Aug 13, 2019
SELL
$15.01 - $18.89 $5.47 Million - $6.89 Million
-364,585 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$16.23 - $20.29 $605,979 - $757,567
-37,337 Reduced 9.29%
364,585 $6.38 Million
Q4 2018

Feb 12, 2019
SELL
$10.77 - $18.44 $233,439 - $399,687
-21,675 Reduced 5.12%
401,922 $6.99 Million
Q3 2018

Nov 15, 2018
SELL
$9.1 - $14.8 $2.7 Million - $4.4 Million
-296,988 Reduced 41.21%
423,597 $5.99 Million
Q2 2018

Aug 15, 2018
BUY
$9.6 - $14.6 $1.48 Million - $2.25 Million
154,068 Added 27.2%
720,585 $6.99 Million
Q1 2018

May 15, 2018
BUY
$5.7 - $12.3 $3.23 Million - $6.97 Million
566,517 New
566,517 $5.64 Million

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.8M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.79B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email